Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

From 2006 to 2019, age-adjusted mortality for liver disease in the US increased by 14% overall and by 24% during COVID, from 2019 through 2021.

Among patients hospitalized with severe gastrointestinal bleeding, there were low rates of diagnosis and treatment of iron deficiency anemia.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy.

Distinct trends were seen in etiology-based mortality with chronic liver disease before, during, and after the COVID-19 pandemic.

The European Union is looking to capitalize on the Trump administration's dismantling of US research programs to beef up its own.

Michael Rogers, associate commissioner for inspections and investigations at the US FDA, announced his retirement.

Maternal deaths increased from 2000 to 2019, with much of the increase attributable to the pregnancy checkbox on death certificates.